TY - JOUR
AU - S. Wang
AU - K. J. Meador
AU - J. Pawasauskas
AU - A. K. Lewkowitz
AU - K. E. Ward
AU - T. N. Brothers
AU - A. Hartzema
AU - B. J. Quilliam
AU - X. Wen
A1 - 
AD - Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, 02881, USA.; Department of Neurology, Stanford University, Palo Alto, CA, USA.; Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI, USA.; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.; College of Health Sciences, University of Rhode Island, Kingston, RI, USA.; Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, 02881, USA. xuerongwen@uri.edu.
AN - 36642778
BT - Drug Saf
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 3
DA - Mar
DO - 10.1007/s40264-022-01267-z
DP - NLM
ET - 20230116
IS - 3
JF - Drug Saf
LA - eng
PY - 2023
SN - 0114-5916 (Print); 0114-5916
SP - 257
EP - 271+
ST - Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study
T1 - Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study
T2 - Drug Saf
TI - Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1007/s40264-022-01267-z
VL - 46
VO - 0114-5916 (Print); 0114-5916
Y1 - 2023
ER -